Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 13Neoplasm Metastasis 3Non-metastatic Castration-resistant Prostate Cancer 2Sleep Initiation and Maintenance Disorders 1Non-metastatic Prostate Cancer 1Metastatic Hormone-sensitive Prostate Cancer 1Fatigue 1Depression 1Advanced Prostate Carcinoma 1

Interventions

Blood Specimen Collection 7Drug Therapy 6Surveys and Questionnaires 5Radiotherapy 5Radiosurgery 5Docetaxel 5Therapeutics 4Specimen Handling 4Immunotherapy 4Hepatectomy 4exemestane 3enzalutamide 3apalutamide 3Trastuzumab 3Hematologic Tests 3Data Collection 3Biopsy 3Biological Assay 3Anastrozole 3Abiraterone Acetate 3trastuzumab deruxtecan 2palbociclib 2darolutamide 2abiraterone 2abemaciclib 2Wearable Electronic Devices 2Triptorelin Pamoate 2Tamoxifen 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Neoplasm Metastasis × apalutamide × Clear all
NCT05701007 2026-01-29

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Pfizer

Completed
1,083 enrolled 29 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06652607 2025-03-12

PSA-DEEP02

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
152 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06473259 2024-06-25

ECHOS

Santa Chiara Hospital

Recruiting
3,000 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡